<code id='094453711B'></code><style id='094453711B'></style>
    • <acronym id='094453711B'></acronym>
      <center id='094453711B'><center id='094453711B'><tfoot id='094453711B'></tfoot></center><abbr id='094453711B'><dir id='094453711B'><tfoot id='094453711B'></tfoot><noframes id='094453711B'>

    • <optgroup id='094453711B'><strike id='094453711B'><sup id='094453711B'></sup></strike><code id='094453711B'></code></optgroup>
        1. <b id='094453711B'><label id='094453711B'><select id='094453711B'><dt id='094453711B'><span id='094453711B'></span></dt></select></label></b><u id='094453711B'></u>
          <i id='094453711B'><strike id='094453711B'><tt id='094453711B'><pre id='094453711B'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:9
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Xenotransplantation trials will require adjusting expectations, experts say
          Xenotransplantation trials will require adjusting expectations, experts say

          RobertMontgomeryofNewYorkUniversityspeaksasMeganSykesofColumbiaUniversityandInsooHyunofHarvardMedica

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Merus drug and Keytruda shrank tumors in patients with head and neck cancer

          ThisimmunofluorescenceimageshowsTcells(ingreenandyellow)inthemicroenvironmentofaheadandnecksquamousc